REPRINT Trademark

Trademark Overview

On Friday, October 28, 2022, a trademark application was filed for REPRINT with the United States Patent and Trademark Office. The USPTO has given the REPRINT trademark a serial number of 79358181. The federal status of this trademark filing is REGISTERED as of Tuesday, March 26, 2024. This trademark is owned by Agendia N.V.. The REPRINT trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical analysis, in particular RNA and DNA analyses for the diagnosis of cancer and for the prognosis of the likely course of cancer
reprint

General Information

Serial Number79358181
Word MarkREPRINT
Filing DateFriday, October 28, 2022
Status700 - REGISTERED
Status DateTuesday, March 26, 2024
Registration Number7333988
Registration DateTuesday, March 26, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 9, 2024

Trademark Statements

Goods and ServicesMedical analysis, in particular RNA and DNA analyses for the diagnosis of cancer and for the prognosis of the likely course of cancer

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 23, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAgendia N.V.
Party Type30 - Original Registrant
Legal Entity Type84 - NOT AVAILABLE
AddressNL
Party NameAgendia N.V.
Party Type20 - Owner at Publication
Legal Entity Type84 - NOT AVAILABLE
AddressNL
Party NameAgendia N.V.
Party Type10 - Original Applicant
Legal Entity Type84 - NOT AVAILABLE
AddressNL

Trademark Events

Event DateEvent Description
Thursday, December 22, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, December 23, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 27, 2022APPLICATION FILING RECEIPT MAILED
Monday, August 14, 2023ASSIGNED TO EXAMINER
Monday, September 25, 2023REFUSAL PROCESSED BY IB
Monday, August 14, 2023NON-FINAL ACTION WRITTEN
Tuesday, August 15, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, September 1, 2023REFUSAL PROCESSED BY MPU
Friday, September 1, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, November 30, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 30, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 1, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 20, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 20, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 20, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Monday, January 8, 2024NOTIFICATION PROCESSED BY IB
Tuesday, January 9, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 26, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, March 26, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Thursday, June 27, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, December 4, 2023APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

reprint cancer prognosis course likely diagnosis analysis particular analyses medical